Display Settings:

Format

Send to:

Choose Destination
We are sorry, but NCBI web applications do not support your browser and may not function properly. More information
    Am J Public Health. 2009 Dec;99(12):2184-7. doi: 10.2105/AJPH.2009.159889. Epub 2009 Oct 15.

    Changes in postmenopausal hormone replacement therapy use among women with high cardiovascular risk.

    Source

    Columbia Presbyterian Medical Center, New York, NY 10032, USA.

    Abstract

    After randomized trials failed to support the use of hormone replacement therapy (HRT) for preventing cardiovascular disease (CVD), HRT use for postmenopausal women declined. Our analysis of 1999-2000 and 2003-2004 National Health and Nutrition Surveys (NHANES) shows that HRT use decreased 19% (from 27.6 to 8.4%; P<.001) among women with CVD versus 3% (from 19.8 to 16.8%; P=.68) among low-risk women, suggesting that most of the drop in HRT use may be among women prescribed HRT as an unproven treatment to prevent CVD.

    PMID:
    19833984
    [PubMed - indexed for MEDLINE]
    PMCID:
    PMC2775780
    Free PMC Article

    Images from this publication.See all images (1)Free text

    FIGURE 1

      Supplemental Content

      Icon for Atypon Icon for PubMed Central

      Save items

      Recent activity

      Your browsing activity is empty.

      Activity recording is turned off.

      Turn recording back on

      See more...
      Write to the Help Desk